CN101830912A - 一种盐酸头孢他美酯化合物及其新制法 - Google Patents
一种盐酸头孢他美酯化合物及其新制法 Download PDFInfo
- Publication number
- CN101830912A CN101830912A CN 201010164684 CN201010164684A CN101830912A CN 101830912 A CN101830912 A CN 101830912A CN 201010164684 CN201010164684 CN 201010164684 CN 201010164684 A CN201010164684 A CN 201010164684A CN 101830912 A CN101830912 A CN 101830912A
- Authority
- CN
- China
- Prior art keywords
- reaction
- hydrochloric acid
- preparation
- acid
- cefetamet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 Cefetamet pivoxil hydrochloride compound Chemical class 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 229950000726 cefetamet pivoxil Drugs 0.000 title claims abstract description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 53
- 238000006243 chemical reaction Methods 0.000 claims abstract description 32
- MQLRYUCJDNBWMV-GHXIOONMSA-N cefetamet Chemical compound N([C@@H]1C(N2C(=C(C)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 MQLRYUCJDNBWMV-GHXIOONMSA-N 0.000 claims abstract description 15
- 229960004041 cefetamet Drugs 0.000 claims abstract description 15
- NVIAYEIXYQCDAN-MHTLYPKNSA-N (6r,7s)-7-azaniumyl-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound S1CC(C)=C(C([O-])=O)N2C(=O)[C@H]([NH3+])[C@@H]12 NVIAYEIXYQCDAN-MHTLYPKNSA-N 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 34
- 238000003756 stirring Methods 0.000 claims description 30
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 16
- 239000007787 solid Substances 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 12
- 230000001105 regulatory effect Effects 0.000 claims description 11
- 238000001291 vacuum drying Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 238000005194 fractionation Methods 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 7
- 239000012044 organic layer Substances 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims description 6
- 238000002425 crystallisation Methods 0.000 claims description 6
- 230000008025 crystallization Effects 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 3
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 2
- 229940043232 butyl acetate Drugs 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 238000004821 distillation Methods 0.000 claims description 2
- 229940093499 ethyl acetate Drugs 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 2
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims description 2
- 229940011051 isopropyl acetate Drugs 0.000 claims description 2
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- DASYMCLQENWCJG-XUKDPADISA-N cefetamet pivoxil Chemical compound N([C@@H]1C(N2C(=C(C)CS[C@@H]21)C(=O)OCOC(=O)C(C)(C)C)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 DASYMCLQENWCJG-XUKDPADISA-N 0.000 abstract description 3
- NLARCUDOUOQRPB-WTKPLQERSA-N (2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetic acid Chemical compound CO\N=C(/C(O)=O)C1=CSC(N)=N1 NLARCUDOUOQRPB-WTKPLQERSA-N 0.000 abstract 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 abstract 1
- PELJISAVHGXLAL-UHFFFAOYSA-N iodomethyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCI PELJISAVHGXLAL-UHFFFAOYSA-N 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 13
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 5
- 235000019345 sodium thiosulphate Nutrition 0.000 description 5
- 238000010025 steaming Methods 0.000 description 4
- 238000000967 suction filtration Methods 0.000 description 4
- 238000010189 synthetic method Methods 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- YHMYGUUIMTVXNW-UHFFFAOYSA-N 1,3-dihydrobenzimidazole-2-thione Chemical compound C1=CC=C2NC(S)=NC2=C1 YHMYGUUIMTVXNW-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- RZKYEQDPDZUERB-UHFFFAOYSA-N Pindone Chemical group C1=CC=C2C(=O)C(C(=O)C(C)(C)C)C(=O)C2=C1 RZKYEQDPDZUERB-UHFFFAOYSA-N 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- CGIHPACLZJDCBQ-UHFFFAOYSA-N acibenzolar Chemical compound SC(=O)C1=CC=CC2=C1SN=N2 CGIHPACLZJDCBQ-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000007867 post-reaction treatment Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Landscapes
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010164684 CN101830912B (zh) | 2010-05-07 | 2010-05-07 | 一种盐酸头孢他美酯化合物及其新制法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010164684 CN101830912B (zh) | 2010-05-07 | 2010-05-07 | 一种盐酸头孢他美酯化合物及其新制法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101830912A true CN101830912A (zh) | 2010-09-15 |
CN101830912B CN101830912B (zh) | 2012-12-26 |
Family
ID=42715147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010164684 Expired - Fee Related CN101830912B (zh) | 2010-05-07 | 2010-05-07 | 一种盐酸头孢他美酯化合物及其新制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101830912B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104788470A (zh) * | 2015-04-30 | 2015-07-22 | 苗怡文 | 一种治疗敏感菌感染性疾病的盐酸头孢他美酯化合物 |
CN104876947A (zh) * | 2015-05-06 | 2015-09-02 | 山东罗欣药业集团股份有限公司 | 盐酸头孢他美酯水合物晶体及其分散片 |
CN104974177A (zh) * | 2015-07-29 | 2015-10-14 | 成都倍特药业有限公司 | 一种盐酸头孢他美酯的晶型ⅱ及其制备方法 |
CN108586491A (zh) * | 2017-12-26 | 2018-09-28 | 山东裕欣药业有限公司 | 一种盐酸头孢他美酯的制备方法 |
CN112409382A (zh) * | 2020-11-26 | 2021-02-26 | 浙江普洛得邦制药有限公司 | 一种盐酸头孢他美酯的合成方法 |
CN113801141A (zh) * | 2020-06-17 | 2021-12-17 | 成都倍特药业股份有限公司 | 一种盐酸头孢他美酯的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1167112A (zh) * | 1996-05-01 | 1997-12-10 | 兰贝克赛实验室有限公司 | 头孢菌素类抗菌素的生产方法 |
US20020120136A1 (en) * | 2001-02-26 | 2002-08-29 | Gwan-Sun Lee | Method of preparing cephalosporins using 4-hydroxyphenylglycine derivatives |
CN101550146A (zh) * | 2009-05-07 | 2009-10-07 | 郑仙锋 | 一种盐酸头孢他美酯化合物及其制法 |
-
2010
- 2010-05-07 CN CN 201010164684 patent/CN101830912B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1167112A (zh) * | 1996-05-01 | 1997-12-10 | 兰贝克赛实验室有限公司 | 头孢菌素类抗菌素的生产方法 |
US20020120136A1 (en) * | 2001-02-26 | 2002-08-29 | Gwan-Sun Lee | Method of preparing cephalosporins using 4-hydroxyphenylglycine derivatives |
CN101550146A (zh) * | 2009-05-07 | 2009-10-07 | 郑仙锋 | 一种盐酸头孢他美酯化合物及其制法 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104788470A (zh) * | 2015-04-30 | 2015-07-22 | 苗怡文 | 一种治疗敏感菌感染性疾病的盐酸头孢他美酯化合物 |
CN104876947A (zh) * | 2015-05-06 | 2015-09-02 | 山东罗欣药业集团股份有限公司 | 盐酸头孢他美酯水合物晶体及其分散片 |
CN104974177A (zh) * | 2015-07-29 | 2015-10-14 | 成都倍特药业有限公司 | 一种盐酸头孢他美酯的晶型ⅱ及其制备方法 |
CN108586491A (zh) * | 2017-12-26 | 2018-09-28 | 山东裕欣药业有限公司 | 一种盐酸头孢他美酯的制备方法 |
CN108586491B (zh) * | 2017-12-26 | 2021-03-02 | 山东裕欣药业有限公司 | 一种盐酸头孢他美酯的制备方法 |
CN113801141A (zh) * | 2020-06-17 | 2021-12-17 | 成都倍特药业股份有限公司 | 一种盐酸头孢他美酯的制备方法 |
CN113801141B (zh) * | 2020-06-17 | 2023-01-20 | 成都倍特药业股份有限公司 | 一种盐酸头孢他美酯的制备方法 |
CN112409382A (zh) * | 2020-11-26 | 2021-02-26 | 浙江普洛得邦制药有限公司 | 一种盐酸头孢他美酯的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101830912B (zh) | 2012-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101830912B (zh) | 一种盐酸头孢他美酯化合物及其新制法 | |
CN102134252B (zh) | 一种高纯头孢呋辛酸的制备方法 | |
CN102391289B (zh) | 头孢他啶中间体及头孢他啶的合成方法 | |
CN102219795B (zh) | 一种头孢替唑钠的制备方法 | |
CN101812076B (zh) | 头孢呋辛钠及其制备方法 | |
CN101948476B (zh) | 一种头孢替安酯盐酸盐的制备方法 | |
CN102617607B (zh) | 一种制备头孢唑啉化合物的方法 | |
CN103467495A (zh) | 一种头孢克肟化合物的制备方法 | |
CN101696214B (zh) | 一种新路线的头孢米诺钠化合物 | |
CN105131017A (zh) | 一种盐酸头孢卡品酯的制备方法 | |
CN109206441A (zh) | 一种依维莫司的纯化方法 | |
CN101921284A (zh) | 头孢硫脒的制备方法 | |
CN104193765B (zh) | 一种头孢克肟的合成方法 | |
CN101704827B (zh) | 一种头孢硫脒化合物的合成方法 | |
CN101817835B (zh) | 一种头孢地尼化合物及其新制法 | |
CN102617601A (zh) | 一种头孢地尼的制备方法 | |
CN101220040A (zh) | 一种头孢克肟的制备及精制方法 | |
CN103183686B (zh) | 7β-氨基-7α-甲氧基-3-头孢烯化合物的制备方法 | |
CN102167705A (zh) | 一种盐酸头孢甲肟的制备方法 | |
CN101550146A (zh) | 一种盐酸头孢他美酯化合物及其制法 | |
CN101768171B (zh) | 头孢泊肟酯化合物的合成方法 | |
CN102391288B (zh) | 头孢匹罗中间体及头孢匹罗的制备方法 | |
CN110407857B (zh) | 一种头孢硫脒的制备工艺 | |
CN102617506B (zh) | 一种头孢地尼及其中间体的制备方法 | |
CN102911186B (zh) | 一种头孢唑肟钠的制备及精制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINAN MEIDA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HU JIANRONG Effective date: 20130724 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 570125 HAIKOU, HAINAN PROVINCE TO: 570216 HAIKOU, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130724 Address after: 570216 C03, Haikou Free Trade Zone, Hainan, China Patentee after: Hainan Meida Pharmaceutical Co., Ltd. Address before: The new business building No. 48 570125 Hainan city of Haikou province China World Trade Center Road, room 2601 Patentee before: Hu Jianrong |
|
DD01 | Delivery of document by public notice |
Addressee: Hainan Meida Pharmaceutical Co., Ltd. Document name: Notification to Pay the Fees |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121226 Termination date: 20160507 |